Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma.
Clin Transl Radiat Oncol
; 34: 42-50, 2022 May.
Article
en En
| MEDLINE
| ID: mdl-35345864
ALK, anaplastic lymphomakinase; BuMel, Busulfan-Melphalan; CBCT, Cone Beam Computed Tomography; CCG, Children's Cancer Group; CI, Confidence interval; CNS, Central Nervous System; COG, Children's Oncology Group; CPHr, Cox proportional hazards regression; CT, Computed Tomography; Cor, Correlation; GD2, Disialoganglioside; HR, Hazard Ratio; IMRT, Intensity Modulated Radiotherapy; LDH, lactate dehydrogenase; MEC, Melphalan-Etoposide-Carboplatin; MIBG, meta-iodobenzylguanidine; MR, Magnetic Resonance Imaging; MS, Metastatic Sites; MSF, Metastatic Site Failure; MYCN, v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog, MYCN proto-oncogene; Maint, Maintenance; Met, Metastasis; SIOP, International Society of Pediatric Oncology; SIOPEN, European SIOP Neuroblastoma Group; cphfR, Cox proportional hazards frailty regression
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Tipo de estudio:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Clin Transl Radiat Oncol
Año:
2022
Tipo del documento:
Article
País de afiliación:
Estados Unidos